Patents Assigned to Syngenix, Ltd.
  • Defective packaging non-oncoviral vectors based on HIV
    Patent number: 6294165
    Abstract: Novel vectors are capable of producing MPMV (Mason-Pfizer Monkey Virus) proteins but not of packaging MPMV RNA, and the information about the packaging signal in MPMV and HIV can be used to create MPMV and HIV vectors that are capable of transferring foreign genes, e.g. for use in gene therapy.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: September 25, 2001
    Assignee: Syngenix, Ltd.
    Inventors: Andrew Michael Lindsay Lever, Eric Hunter